| Anti-CMV IgM(+) patients | Anti-CMV IgM(-)IgG(+) patients |
---|---|---|
n | 20 | 39 |
U1RNP | 37% (7/20) | 31% (12/39) |
Sm | 0% (0/20) | 15% (6/39) |
Sm/U1RNP | 0% (0/7) | 50% (6/12)* |
Ribosomal P | 5% (1/20) | 10% (4/39) |
RNA helicase A | 15% (3/20) | 26% (10/39) |
Ro | 35% (7/20) | 38% (15/39) |
La | 15% (3/20) | 8% (3/39) |
Ku | 10% (2/20) | 5% (2/39) |
Su | 30% (6/20) | 23% (9/39) |
RNA polymerase II | 10% (2/20) | 8% (3/39) |
U1RNP/Sm ELISA > 25 units | 0% (0/20) | 28% (11/39)†|